Lyell Immunopharma, Inc. Contracts & Agreements

42 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Severance Waiver by and between the Registrant and Stephen Hill, dated April 19, 2022
Severance Agreements
Lyell Immunopharma, Inc.
Biotechnology
CA
2022
Registration Rights Agreement, dated as of October 31, 2024, by and among Lyell Immunopharma, Inc., each of the Sellers Party thereto and WT Representative LLC, solely in its...
Registration Rights Agreements
Lyell Immunopharma, Inc.
2024
Agreement and Plan of Merger, dated as of October 24, 2024, by and among ImmPACT Bio USA Inc., Lyell Immunopharma, Inc., Inspire Merger Sub Inc. and WT Representative LLC, solely...
Merger Agreements
Lyell Immunopharma, Inc.
2024
Lyell Immunopharma, Inc. Non-Employee Director Compensation Policy
Compensation Agreements
Lyell Immunopharma, Inc.
2024
Offer Letter by and between the Registrant and Gary Lee, dated November 24, 2021
Lyell Immunopharma, Inc.
2024
Non-Employee Director Compensation Policy
Compensation Agreements
Lyell Immunopharma, Inc.
2023
Offer Letter by and between the Registrant and Matthew Lang, dated May 12, 2023
Lyell Immunopharma, Inc.
2023
Release and Separation Agreement
Separation Agreements
Lyell Immunopharma, Inc.
2023
Description of Securities
Lyell Immunopharma, Inc.
Biotechnology
2023
Separation, Transition and General Release Agreement, by and between Elizabeth Homans and Lyell Immunopharma, Inc., dated December 15, 2022
Separation Agreements
Lyell Immunopharma, Inc.
2022
Offer Letter, by and between Lynn Seely and Lyell Immunopharma, Inc., dated December 14, 2022
Lyell Immunopharma, Inc.
2022
Offer Letter by and between the Registrant and Rahsaan
Lyell Immunopharma, Inc.
Biotechnology
CA
2022
Notice and Acceptance of Amendment to Stock Options between the Registrant and Elizabeth Homans, dated
Stock Agreements
Lyell Immunopharma, Inc.
2022
Second Amendment to the Collaboration and License Agreement between the Registrant, GlaxoSmithKline Intellectual Property (No.5) Limited and Glaxo Group Limited, dated December...
Collaboration Agreements
Lyell Immunopharma, Inc.
2022
Lyell Immunopharma, Inc. Officer Severance Plan
Severance Agreements
Lyell Immunopharma, Inc.
2022
Lyell Immunopharma, Inc. 2021 Equity Incentive Plan
Bonus & Incentive Agreements
Lyell Immunopharma, Inc.
Biotechnology
DE
2021
Collaboration and License Agreement by and between the Registrant, GlaxoSmithKline Intellectual Property (No. 5) Limited and Glaxo Group Limited, dated May 23, 2019, as amended
Collaboration Agreements
Lyell Immunopharma, Inc.
2021
Lyell Immunopharma, Inc. 2021 Non-Employee Director Compensation Policy
Compensation Agreements
Lyell Immunopharma, Inc.
2021
Lyell Immunopharma, Inc. 2021 Employee Stock Purchase Plan
Stock Agreements
Lyell Immunopharma, Inc.
Biotechnology
2021
Forms of Restricted Stock Unit Grant Notice and Award Agreement under the Lyell Immunopharma, Inc. 2021 Equity Incentive Plan
Bonus & Incentive Agreements
Lyell Immunopharma, Inc.
Biotechnology
DE
2021
Forms of Stock Option Grant Notice, Stock Option Agreement and Notice of Exercise under the Lyell Immunopharma, Inc. 2021 Equity Incentive Plan
Bonus & Incentive Agreements
Lyell Immunopharma, Inc.
2021
Form of Common Stock Certificate
Stock Agreements
Lyell Immunopharma, Inc.
Biotechnology
2021
Form of Underwriting Agreement
Underwriting Agreements
Lyell Immunopharma, Inc.
2021
Lyell Immunopharma, Inc. 2018 Equity Incentive Plan, as amended
Bonus & Incentive Agreements
Lyell Immunopharma, Inc.
Biotechnology
CA
2021
Amended and Restated Investors Rights Agreement, by and among the Registrant and certain of its stockholders, dated March 5, 2020
Investor Rights Agreements
Lyell Immunopharma, Inc.
2021
Forms of Stock Option Grant Notice, Stock Option Agreement and Notice of Exercise and Restricted Stock Award Agreement under the Lyell Immunopharma, Inc. 2018 Equity Incentive Plan
Bonus & Incentive Agreements
Lyell Immunopharma, Inc.
Biotechnology
CA
2021
Lyell Immunopharma, Inc. Officer Severance Plan
Severance Agreements
Lyell Immunopharma, Inc.
2021
Form of Indemnification Agreement by and between the Registrant and its directors and executive officers
Indemnification Agreements
Lyell Immunopharma, Inc.
Biotechnology
DE
2021
Amended Offer Letter by and between the Registrant and Richard Klausner, dated July 23, 2020
Lyell Immunopharma, Inc.
2021
Amended Offer Letter by and between the Registrant and Elizabeth Homans, dated July 23, 2020
Lyell Immunopharma, Inc.
2021
Offer Letter by and between the Registrant and Charles Newton, dated February 3, 2021
Lyell Immunopharma, Inc.
Biotechnology
CA
2021
Offer Letter by and between the Registrant and Heather Turner, dated February 1, 2019
Lyell Immunopharma, Inc.
2021
Offer Letter by and between the Registrant and Stephen Hill, dated May 9, 2019
Lyell Immunopharma, Inc.
2021
Collaboration and License Agreement by and between the Registrant, GlaxoSmithKline Intellectual Property (No. 5) Limited and Glaxo Group Limited, dated May 23, 2019, as amended
Collaboration Agreements
Lyell Immunopharma, Inc.
Biotechnology
CA
2021
License Agreement by and between the Registrant and The Board of Trustees of the Leland Stanford Junior University, dated January 29, 2019
License Agreements
Lyell Immunopharma, Inc.
Biotechnology
CA
2021
Success Payment Agreement, by and between the Registrant and The Board of Trustees of the Leland Stanford Junior University, dated October 1, 2020
Lyell Immunopharma, Inc.
2021
Success Payment Agreement, by and between the Registrant and Fred Hutchinson Cancer Research Center, dated December 19, 2018
Lyell Immunopharma, Inc.
2021
Standard Office Lease for Building C by and between the Registrant and Bre Wa Office Owner LLC, dated August 28, 2019
Lease Agreements
Lyell Immunopharma, Inc.
Biotechnology
WA
2021
Standard Office Lease for Building E by and between the Registrant and Bre Wa Office Owner LLC, dated August 28, 2019
Lease Agreements
Lyell Immunopharma, Inc.
2021
Lease by and between the Registrant and BMR-500 Fairview Avenue LLC, dated November 27, 2018, as amended
Lease Agreements
Lyell Immunopharma, Inc.
Biotechnology
CA
2021
Lease Agreement by and between the Registrant and ARE-San Francisco No. 65, LLC, dated August 15, 2019, as amended
Lease Agreements
Lyell Immunopharma, Inc.
Biotechnology
2021
Lease Agreement by and between the Registrant and ARE-East Jamie Court, LLC, dated January 14, 2019, as amended
Lease Agreements
Lyell Immunopharma, Inc.
2021